The inhibitory receptor ILT3 is a highly sensitive and specific marker for both diagnosis and monitoring of AML with monocytic differentiation; ILT3 as a marker is particularly useful in the differential diagnosis of AML with monocytic differentiation and microgranular acute promyelocytic leukemia, two leukemia subtypes that require different treatment strategies27. This evidence concerns the gene LILRB4 and leukemia.